NanoSurface Biomedical

NanoSurface Biomedical is accelerating drug development with human-relevant stem cell-based assays. At NanoSurface, we believe that cells in the dish should resemble cells in the body. We use bioengineering techniques  to enhance nearly all endpoint assays in an instrument- and cell-agnostic manner. Our biomimetic nanopatterning technology imitates the geometry of the native extracellular matrix and drives the organization, migration, proliferation, and phenotypic development and maturity of many cell types. The NanoSurface Car(ina) platform uses extracellular matrix cues to drive the maturity of iPSC-derived cardiomyocytes, making these cell models more representative of human biology. The NanoSurface Cytostretcher family of cell stretching instruments enables researchers to apply programmable stretch routines to flexible nanopatterned culture substrates, either in the incubator or on an optical microscope stage, to explore the effects of mechanical stimulation on the maturation of cell and tissue cultures. The NanoSurface eCyte 6 is an electrical stimulation system for long-term electrical stimulation and pacing of excitable cells in vitro. Our suite of technologies is driven by our goal to greatly improve the predictive power of cell based assays